Prakash Narayan, PhD

As Vice-President of Preclinical Research at Angion Biomedica Corp., NY, Prakash Narayan, PhD, brings 12 years of translational research expertise in acute kidney and liver injury and chronic kidney and liver disease. He is the recipient of 23 US federal agency awards (NIH, NSF and DoD) relating to development of drugs in these indications one of which is in Phase II clinical trial in renal recipients at risk for delayed graft function. More recently, Dr. Narayan is working toward identification of a unique panel of biomarkers with increased prognosticative value in polycystic kidney disease.